PTAB
Advanced fields
1 decision · 330msnewest first
  • PTAB · May 1, 2025 · IPR2025-00081 · APJ Karl D Easthom · IPR · Institution

    The Board denied institution on all challenged claims because the district court had already held those claims invalid under § 101.

    RulingsInstitution decision
    • PTAB / AIA Trials › Discretionary denial › Fintiv (parallel litigation)Institution denied fintivInstitution denied

      “IPR2024-01252 and IPR2024-01253) reached the opposite conclusion to that of AviaGames in holding that a district court’s § 101 invalidity judgment precludes instituting challenges to the invalid claims even though an appeal of that judgment is pending. Specifically, in Hulu, LLC v. Piranha Media Distribution, LLC, IPR2024-01252, -01253, Paper 27 (PTAB April 17, 2025) (Director Review decision) (“Hulu”), the Acting Director held that “[b]ecause the patent claims already stand invalid [due to a district court’s § 101 invalidity judgment], it is unnecessary to institute another proceeding to review them for patentability under other grounds.” Hulu at 2, 3 (reasoning that “[i]n the event the Federal Circuit reverses the district court’s decision, Petitioner may raise such invalidity arguments in the district court on remand”) (remanding the panel’s institution decisions and denying institution). Accordingly, under clear guidance from Hulu, because the District Court held all the ’403 patent claims invalid under § 101, we deny institution. See Hulu at 3 (holding that “where a district court already has found the challenged claims invalid, the efficiency and integrity of the patent system is best served by denying institution” (citing Fintiv at 16)).” slip op. at 8

    Discretionary denial
    Patents in suitUS 10,986,403

Holdings, summaries, rulings, issues, outcomes, winners and claim constructions shown for a decision were generated by a large language model reading the opinion. They are a guide to the decision, not the decision. Confirm every one against the court's own text before relying on it. Outcomes read from the patent owner’s side. Party names are extracted from the decision and are missing on about 900 short Director denials and scans, which carry the trial number instead.